How to Respond to an FDA Warning Letter

 

fda warning letter api

The FDA has issued a warning letter for a German contract manufacturer for violations of good manufacturing practices. These include failing to provide stability data for APIs shipped to the US in 2012. It also failed to include retesting of already distributed APIs. The FDA recommends a thorough review of API manufacturing processes to ensure they are compliant with FDA regulations. For more information, see the FDA Warning Letter. If you receive an API warning, follow these steps to get your company back on track.

The FDA issues Warning Letters to manufacturers who are in serious violation of federal regulations. These letters are a signal of a serious regulatory violation, and recipients must take immediate corrective action. The FDA has determined that a company has violated FDCA regulations if it has not maintained a complaint file or is making inappropriate claims about a product's function. If a firm fails to meet FDA requirements, the agency will issue an API warning letter and may initiate enforcement actions.

The FDA issued the warning letter because three API repackers failed to comply with CGMPs. In these cases, the APIs were repackaged without further processing and were shipped to drug manufacturers, compounding pharmacies, and outsourcing facilities. Because these companies did not adhere to CGMPs, their products may contain contaminated products. If a company continues to ignore the FDA's warning letter, it may face additional enforcement action.

Comments

Popular posts from this blog

The Mailings API

Send a Letter Script Using the Send Letter API